A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Venlafaxine Hydrochloride Extended-Release Capsules 150 mg and Efexor XR 150 mg Capsules in healthy, adult, Thai volunteers under fasting condition

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: d4c36c0c36350453803a66cbc450456e4bc9cc8b
First added on: Apr 11, 2025